498 related articles for article (PubMed ID: 36183780)
1. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M
Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780
[TBL] [Abstract][Full Text] [Related]
2. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
Chang X; Ismail NI; Rahman A; Xu D; Chan RWY; Ong SG; Ong SB
Antioxid Redox Signal; 2023 Mar; 38(7-9):599-618. PubMed ID: 36053670
[No Abstract] [Full Text] [Related]
3. Cardiovascular complications in COVID-19.
Long B; Brady WJ; Koyfman A; Gottlieb M
Am J Emerg Med; 2020 Jul; 38(7):1504-1507. PubMed ID: 32317203
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Complications in Coronavirus Disease 2019-Pathogenesis and Management.
Restrepo MI; Marin-Corral J; Rodriguez JJ; Restrepo V; Cavallazzi R
Semin Respir Crit Care Med; 2023 Feb; 44(1):21-34. PubMed ID: 36646083
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Involvement of COVID-19: A Comprehensive Review.
Chang WT; Toh HS; Liao CT; Yu WL
Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633
[TBL] [Abstract][Full Text] [Related]
6. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.
Li N; Zhu L; Sun L; Shao G
Stem Cell Res; 2021 Mar; 51():102168. PubMed ID: 33485182
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
Abdel Moneim A; Radwan MA; Yousef AI
Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
[TBL] [Abstract][Full Text] [Related]
8. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
9. The potential role of SARS-CoV-2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread.
Alsaidan AA; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Alsayed KA; Saad HM; Batiha GE
Immun Inflamm Dis; 2023 Mar; 11(3):e798. PubMed ID: 36988260
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Complications of Coronavirus Disease-2019.
Terzic CM; Medina-Inojosa BJ
Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):551-561. PubMed ID: 37419531
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and its long-term impact on the cardiovascular system.
Philip B; Mukherjee P; Khare Y; Ramesh P; Zaidi S; Sabry H; Harky A
Expert Rev Cardiovasc Ther; 2023 Mar; 21(3):211-218. PubMed ID: 36856339
[TBL] [Abstract][Full Text] [Related]
12. COVID-19's immuno-pathology and cardiovascular diseases.
Nasab EM; Aghajani H; Makoei RH; Athari SS
J Investig Med; 2023 Feb; 71(2):71-80. PubMed ID: 36647329
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).
Cenko E; Badimon L; Bugiardini R; Claeys MJ; De Luca G; de Wit C; Derumeaux G; Dorobantu M; Duncker DJ; Eringa EC; Gorog DA; Hassager C; Heinzel FR; Huber K; Manfrini O; Milicic D; Oikonomou E; Padro T; Trifunovic-Zamaklar D; Vasiljevic-Pokrajcic Z; Vavlukis M; Vilahur G; Tousoulis D
Cardiovasc Res; 2021 Dec; 117(14):2705-2729. PubMed ID: 34528075
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular aspects of COVID-19.
Kurz DJ; Eberli FR
Swiss Med Wkly; 2020 Dec; 150():w20417. PubMed ID: 33382450
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.
Luo J; Zhu X; Jian J; Chen X; Yin K
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):273-282. PubMed ID: 33428706
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.
Soumya RS; Unni TG; Raghu KG
Cardiovasc Drugs Ther; 2021 Jun; 35(3):411-425. PubMed ID: 32926272
[TBL] [Abstract][Full Text] [Related]
18. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
19. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?
Ozieranski K; Tyminska A; Jonik S; Marcolongo R; Baritussio A; Grabowski M; Filipiak KJ; Opolski G; Caforio ALP
J Card Fail; 2021 Jan; 27(1):92-96. PubMed ID: 33166657
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges.
Shah KS; Hale Hammond ME; Drakos SG; Anderson JL; Fang JC; Knowlton KU; Shaw RM
Future Cardiol; 2021 Oct; 17(7):1277-1291. PubMed ID: 33739142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
